Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-β1

Journal of Immunology

Volumn 160, Issue 3, 1998, Pages 1198-1203

  Kim, Pyeung Hyeun ^a   Eckmann, Lars ^b   Lee, Wha Jung ^a   Han, Wonkyo ^a   Kagnoff, Martin F ^b,c  

^a Kangwon National University   (South Korea)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SWITCHING; GROWTH INHIBITION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; CHOLERA TOXIN; GROWTH INHIBITORS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; SPLEEN; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031941568     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Coffman, R. L., D. A. Lebman, and B. Shrader. 1989. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170:1039.
2. Sonoda, E., R. Matsumoto, Y. Hitoshi, T. Ishii, M. Sugimoto, S. Araki, A. Tominaga, N. Yamaguchi, and K. Takatsu. 1989. Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170:1415.
3. Kim, P. H., and M. F. Kagnoff. 1990. Transforming growth factor β1 increases IgA isotype switching at the clonal level. J. Immunol. 145:3773.
4. van Vlasselaer, P., J. Punnonen, and J. E. de Vries. 1992. Transforming growth factor-β directs IgA switching in human B cells. J. Immunol. 148:2062.
5. Murray, P. D., D. T. McKenzie, S. L. Swain, and M. F. Kagnoff. 1987. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J. Immunol. 139:2669.
6. Schoenbeck, S., D. T. McKenzie, and M. F. Kagnoff. 1989. Interleukin 5 is a differentiation factor for IgA B cells. Eur. J. Immunol. 19:965.
7. Kunimoto, D. Y., R. P. Nordan, and W. Strober. 1989. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J. Immunol. 143:2230.
8. Beagley, K. W., J. H. Eldridge, F. Lee, H. Kiyono, M. P. Everson, W. J. Koopman, T. Hirano, T. Kishimoto, and J. R. McGhee. 1989. Interleukins and IgA synthesis: human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169:2133.
9. Briere, F., J. M. Bridon, D. Chevet, G. Souillet, F. Bienvenu, C. Guret, H. Martinez-Valdez, and J. Banchereau. 1994. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J. Clin. Invest. 94:97.
10. Kitani, A., and W. Strober. 1994. Differential regulation of Cα1and Cα2 germline and mature mRNA transcripts in human peripheral blood B cells. J. Immunol. 153:1466.
11. Holmgren, J. 1981. Actions of cholera toxin and the prevention and treatment of cholera. Nature 292:413.
12. Zhang, R. G., D. L. Scott, M. L. Westbrook, S. Nance, B. D. Spangler, G. G. Shipley, and E. M. Westbrook. 1995. The three-dimensional crystal structure of cholera toxin. J. Mol. Biol. 251:563.
13. Hyun, C. S., and G. A. Kimmich. 1984. Interaction of cholera toxin and Escherichia coli enterotoxin with isolated intestinal epithelial cells. Am. J. Physiol. 247:G623.
14. Spangler, B. D. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622.
15. Elson, C. O., and W. Ealding. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133:2892.
16. Wilson, A. D., C. J. Clarke, and C. R. Stokes. 1990. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand. J. Immunol. 31:443.
17. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309.
18. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, and H. Bluethmann. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155:4621.
19. Elson, C. O., and W. Ealding. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736.
20. Lycke, N., E. Severinson, and W. Strober. 1990. Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation. J. Immunol. 145:3316.
21. Pierre, P., O. Denis, H. Bazin, E. Mbongolo Mbella, and J. P. Vaerman. 1992. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit. Eur. J. Immunol. 22:3179.
22. Stok, W., P. J. van der Heijden, and A. T. Bianchi. 1994. Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit. Vaccine 12: 521.
23. Wu, H. Y., and M. W. Russell. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61:314.
24. Sun, J. B., C. Rask, T. Olsson, J. Holmgren, and C. Czerkinsky. 1996. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 93:7196.
25. Bergerot, I., C. Ploix, J. Petersen, V. Moulin, C. Rask, N. Fabien, M. Lindblad, A. Mayer, C. Czerkinsky, J. Holmgren, and C. Thivolet. 1997. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94:4610.
26. Lycke, N., and W. Strober. 1989. Cholera toxin promotes B cell isotype differentiation. J. Immunol. 142:3781.
27. Whitmore, A. C., D. M. Prowse, G. Haughton, and L. W. Arnold. 1991. Ig isotype switching in B lymphocytes: the effect of T cell-derived interleukins, cytokines, cholera toxin, and antigen on isotype switch frequency of a cloned B cell lymphoma. Int. Immunol. 3:95.
28. Lebman, D. A., J. A. Fuhrman, and J. J. Cebra. 1988. Intraduodenal application of cholera holotoxin increases the potential of clones from Peyer's patch B cells of relevant and unrelated specificities to secrete IgG and IgA. Reg. Immunol. 1:32.
29. Marshak-Rothstein, A., P. Fink, T. Gridley, D. H. Raulet, M. J. Bevan, and M. L. Gefter. 1979. Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J. Immunol. 122:2491.
30. Raulet, D. H., P. D. Gottlieb, and M. J. Bevan. 1980. Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1. J. Immunol. 125:1136.
31. Ceredig, R., J. W. Lowenthal, M. Nabholz, and H. R. MacDonald. 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.
32. Derynck, R., J. A. Jarrett, E. Y. Chen, and D. V. Goeddel. 1986. The murine transforming growth factor-β precursor. J. Biol. Chem. 261:4377.
33. Kim, P. H., and M. F. Kagnoff. 1990. Transforming growth factor-β1 is a costimulator for IgA production. J. Immunol. 144:3411.
34. Danielpour, D., L. L. Dart, K. C. Flanders, A. B. Roberts, and M. B. Sporn. 1989. Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol. 138:79.
35. s) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin. J. Immunol. 156:2894.
36. Eckmann, L., E. Morzycka-Wroblewska, J. R. Smith, and M. F. Kagnoff. 1992. Cytokine-induced differentiation of IgA B cells: studies using an IgA expressing B-cell lymphoma. Immunology 76:235.
37. Snapper, C. M., W. Waegell, H. Beernink, and J. R. Dasch. 1993. Transforming growth factor-β1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J. Immunol. 151:4625.
38. + B cell lymphoma, CH12, expressing isotypes other than IgM. J. Immunol. 140:4355.
39. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmmune diseases. Immunol. Today 18:335.
40. Neurath, M. F., I. Fuss, B. L. Kelsall, D. H. Presky, W. Waegell, and W. Strober. 1996. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 183:2605.
41. Sun, J. B., J. Holmgren, and C. Czerkinsky. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91:10795.
42. Challacombe, S. J., and T. B. Tomasi. 1980. Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 152:1459.
43. Kagnoff, M. F. 1996. Oral tolerance: mechanisms and possible role in inflammatory joint diseases. Bailliere's Clin. Rheumatol. 10:41.
44. Fujihashi, K., J. R. McGhee, M. Yamamoto, T. Hiroi, and H. Kiyono. 1996. Role of gamma delta T cells in the regulation of mucosal IgA response and oral tolerance. Ann. N. Y. Acad. Sci. 778:55.